Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Tic Disorders 1Intellectual Disability 1Epilepsy 1Developmental Disabilities 1Cerebrovascular Disorders 1Brain Neoplasms 1Autistic Disorder 1Attention Deficit Disorder with Hyperactivity 1

Interventions

pembrolizumab 589Cyclophosphamide 539Magnetic Resonance Spectroscopy 523Radiotherapy 506Specimen Handling 503Nivolumab 407Cisplatin 370Carboplatin 358Biopsy 304Blood Specimen Collection 295Radiosurgery 283Paclitaxel 274Surveys and Questionnaires 268Standard of Care 266Gemcitabine 265fludarabine 261Dexamethasone 258Drug Therapy 256venetoclax 246Bevacizumab 246Oxaliplatin 206Rituximab 195Capecitabine 194Radiation 189Fluorouracil 186Ipilimumab 184durvalumab 180Doxorubicin 175atezolizumab 172Etoposide 171

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Magnetoencephalography × 1 year × Clear all
NCT06668519 2026-03-25

Magnetoencephalography in Children

Children's Hospital of Fudan University

Recruiting
1,500 enrolled
CNS

Attention Deficit Disorder with Hyperactivity, Autistic Disorder, Brain Neoplasms, Cerebrovascular Disorders, Developmental Disabilities, Epilepsy, Intellectual Disability, Tic Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡